David A. Isenberg
AuthID: R-006-E33
21
TITLE: Can we predict if patients with SLE will require more than one cycle of rituximab?
AUTHORS: Gonzalez, RF; Abida, R; Gisca, E; Duarte, L; Isenberg, DA;
PUBLISHED: 2021, SOURCE: RHEUMATOLOGY
AUTHORS: Gonzalez, RF; Abida, R; Gisca, E; Duarte, L; Isenberg, DA;
PUBLISHED: 2021, SOURCE: RHEUMATOLOGY
INDEXED IN: 
WOS
WOS22
TITLE: Towards Precision Medicine in Systemic Lupus Erythematosus
AUTHORS: Elliott Lever; Marta R Alves; David A Isenberg;
PUBLISHED: 2020, SOURCE: PHARMACOGENOMICS & PERSONALIZED MEDICINE, VOLUME: 13
AUTHORS: Elliott Lever; Marta R Alves; David A Isenberg;
PUBLISHED: 2020, SOURCE: PHARMACOGENOMICS & PERSONALIZED MEDICINE, VOLUME: 13
INDEXED IN: 
Scopus WOS
Scopus WOS23
TITLE: "Mixed connective tissue disease": a condition in search of an identity Full Text
AUTHORS: Marta R Alves; David A Isenberg;
PUBLISHED: 2020, SOURCE: CLINICAL AND EXPERIMENTAL MEDICINE, VOLUME: 20, ISSUE: 2
AUTHORS: Marta R Alves; David A Isenberg;
PUBLISHED: 2020, SOURCE: CLINICAL AND EXPERIMENTAL MEDICINE, VOLUME: 20, ISSUE: 2
INDEXED IN: Scopus WOS
Scopus WOS24
TITLE: Why do some patients with systemic lupus erythematosus fail to respond to B-cell depletion using rituximab?
AUTHORS: Freitas, S; Mozo Ruiz, MM; Costa Carneiro, AC; Isenberg, DA;
PUBLISHED: 2020, SOURCE: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, VOLUME: 38, ISSUE: 2
AUTHORS: Freitas, S; Mozo Ruiz, MM; Costa Carneiro, AC; Isenberg, DA;
PUBLISHED: 2020, SOURCE: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, VOLUME: 38, ISSUE: 2
INDEXED IN: WOS
WOS25
TITLE: The assessment of patients with the antiphospholipid antibody syndrome: where are we now?
AUTHORS: Pedro Gaspar; Hannah Cohen; David A Isenberg;
PUBLISHED: 2020, SOURCE: RHEUMATOLOGY, VOLUME: 59, ISSUE: 7
AUTHORS: Pedro Gaspar; Hannah Cohen; David A Isenberg;
PUBLISHED: 2020, SOURCE: RHEUMATOLOGY, VOLUME: 59, ISSUE: 7
INDEXED IN: Scopus WOS
Scopus WOS26
TITLE: Comparison of Three Classification Criteria Sets for Systemic Lupus Erythematosus: A Study Looking at Links to Outcome and Mortality Full Text
AUTHORS: Antonio Costa Carneiro; Marta Mozo Ruiz; Sara Freitas; David Isenberg;
PUBLISHED: 2020, SOURCE: ARTHRITIS CARE & RESEARCH, VOLUME: 72, ISSUE: 11
AUTHORS: Antonio Costa Carneiro; Marta Mozo Ruiz; Sara Freitas; David Isenberg;
PUBLISHED: 2020, SOURCE: ARTHRITIS CARE & RESEARCH, VOLUME: 72, ISSUE: 11
INDEXED IN: WOS
WOS27
TITLE: Recent developments in biologic therapies for the treatment of patients with systemic lupus erythematosus
AUTHORS: Pedro L Carreira; David A Isenberg;
PUBLISHED: 2019, SOURCE: RHEUMATOLOGY, VOLUME: 58, ISSUE: 3
AUTHORS: Pedro L Carreira; David A Isenberg;
PUBLISHED: 2019, SOURCE: RHEUMATOLOGY, VOLUME: 58, ISSUE: 3
INDEXED IN: WOS
WOS28
TITLE: Do anti-neutrophil cytoplasmic antibodies play a role in systemic lupus erythematosus (SLE) patients? Analysis of the University College Hospital SLE cohort
AUTHORS: Sobral, S; Ramassur, K; Apsley, E; Isenberg, D;
PUBLISHED: 2018, SOURCE: LUPUS, VOLUME: 27, ISSUE: 2
AUTHORS: Sobral, S; Ramassur, K; Apsley, E; Isenberg, D;
PUBLISHED: 2018, SOURCE: LUPUS, VOLUME: 27, ISSUE: 2
INDEXED IN: Scopus WOS
Scopus WOS29
TITLE: Very delayed lupus nephritis: a report of three cases and literature review
AUTHORS: Andre R Alexandre; Pedro L Carreira; David A Isenberg;
PUBLISHED: 2018, SOURCE: LUPUS SCIENCE & MEDICINE, VOLUME: 5, ISSUE: 1
AUTHORS: Andre R Alexandre; Pedro L Carreira; David A Isenberg;
PUBLISHED: 2018, SOURCE: LUPUS SCIENCE & MEDICINE, VOLUME: 5, ISSUE: 1
INDEXED IN: WOS
WOS30
TITLE: Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus
AUTHORS: Rita Quelhas da Costa; Elena Aguirre Alastuey, ME; David A Isenberg; Amanda M Saracino;
PUBLISHED: 2018, SOURCE: JAMA DERMATOLOGY, VOLUME: 154, ISSUE: 12
AUTHORS: Rita Quelhas da Costa; Elena Aguirre Alastuey, ME; David A Isenberg; Amanda M Saracino;
PUBLISHED: 2018, SOURCE: JAMA DERMATOLOGY, VOLUME: 154, ISSUE: 12
INDEXED IN: Scopus WOS
Scopus WOS